CORRECTION article

Front. Pharmacol., 14 July 2023

Sec. Obstetric and Pediatric Pharmacology

Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1254518

Corrigendum: Research advances in drug therapy of endometriosis

  • 1. Department of Pharmacy, Sichuan Academy of Medical Sciences and Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China

  • 2. Personalized Drug Therapy Key Laboratory of Sichuan Province, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China

  • 3. Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China

  • 4. Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, China

  • 5. Pharmacy College, Chengdu University of Traditional Chinese Medicine, Chengdu, China

  • 6. Miller School of Medicine, University of Miami, Miami, FL, United States

  • 7. Department of Chemistry and Biochemisty, Florida International University, Miami, FL, United States

  • 8. College of Food and Bioengineering, Xihua University, Chengdu, China

In the published article, there was an error in affiliation 3. Instead of “Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu 610072, China”, it should be “Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China”. There was also an error in affiliation 4. Instead of “Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China”, it should be “Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, China.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

endometriosis, pathogenesis, medical treatment, gonadotropin-releasing antagonist, aromatase inhibitor

Citation

Shi J, Tan X, Feng G, Zhuo Y, Jiang Z, Banda S, Wang L, Zheng W, Chen L, Yu D and Guo C (2023) Corrigendum: Research advances in drug therapy of endometriosis. Front. Pharmacol. 14:1254518. doi: 10.3389/fphar.2023.1254518

Received

07 July 2023

Accepted

10 July 2023

Published

14 July 2023

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

14 - 2023

Updates

Copyright

*Correspondence: Lu Chen, ; Dongke Yu, ; Chun Guo,

†These authors have contributed equally to this work and share first authorship

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics